|
Partnering with QPS for a well-conceived and well-executed IND-enabling preclinical program will provide you with a detailed assessment of your drug candidate and the most agile, flexible and timely pathway to filing an IND.
Before we begin executing your IND-enabling preclinical program, you will receive a strategic review and advice on the design and execution of your ADME and pharmacology-toxicology studies.
During execution of your IND-enabling program you will benefit from QPS’s operational strengths, strong scientific/regulatory pre-IND/IND support, and drug development experience.
|